Vanguard Portfolio Management
ZBH icon

Vanguard Portfolio Management’s Zimmer Biomet ZBH Stock Holding History

Vanguard Portfolio Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$727M Sell
8,441,747
-208,481
-2% -$18.3M 0.03% 550
2026
Q1 		$782M Buy
+8,650,228
New +$794M 0.04% 491

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Portfolio Management's ZBH Position: Q2 2026 in Review

Vanguard Portfolio Management reduced its Zimmer Biomet (ZBH) stake by 2.4% in Q2 2026, selling an estimated $18.3M and leaving 8,441,747 shares worth $727M. The position accounts for 0.03% of the portfolio, ranked #550.

Vanguard Portfolio Management first reported a position in ZBH in Q1 2026 and has held it in 2 quarters since. The position peaked at $782M in Q1 2026. 853 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Vanguard Portfolio Management held 8,441,747 shares of Zimmer Biomet worth $727M as of Q2 2026.
  • Vanguard Portfolio Management sold 208,481 Zimmer Biomet shares in Q2 2026, an estimated $18.3M.
  • Zimmer Biomet made up 0.03% of Vanguard Portfolio Management's portfolio in Q2 2026, its #550 holding.
  • Vanguard Portfolio Management first reported a position in Zimmer Biomet in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Portfolio Management's Zimmer Biomet position peaked at $782M in Q1 2026.
  • 853 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.